Success in Using Stem Cells to Treat Acute Kidney Injury


Acute Kidney Injury (AKI) is the rapid loss of kidney function, with death rate of more than 60 percent among intensive care patients. Using induced pluripotent stem cells (iPSC) has been found to be more successful than conventional methods for treating AKI. Professor Kenji Osafune and his team of researchers at Centre for iPS Cell Research and Application (CiRA) at Kyoto University worked with scientists from Astellas Pharma Inc., to develop a protocol that used kidney progenitor cells to form structures that resembled proximal renal tubules.